Determinants of response to the glucagon-like peptide-1 receptor agonists in a type 2 diabetes population in the real-world

To identify clinical predictors associated with a response in terms of glycemic control and weight loss in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonists (GLP-1RAs).

Détails bibliographiques
Publié dans:A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients. - 2016. - Amsterdam [u.a.]
Auteur principal: Franch-Nadal, Josep (Auteur)
Autres auteurs: Granado-Casas, Minerva (Autre), Mata-Cases, Manel (Autre), Ortega, Emilio (Autre), Vlacho, Bogdan (Autre), Mauricio, Didac (Autre)
Format: Article en ligne
Langue:English
Publié: 2022
Accès à la collection:A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients
Sujets:eGFR FDA OR CI ITT SIDIAP EASD MPR RCTs GLP-1RAs plus... ICS NIADs NICE DPP4i CKD-EPI HbA1c SGLT2i ADA BMI WHO
Description matérielle:8